Privacy and Data Security: A Webinar for Life Sciences and Health Information Technology Companies

Privacy and Data Security: A Webinar for Life Sciences and Health Information Technology Companies

Speaking Engagement

From protecting clinical data to complying with HIPAA and HITECH standards, life sciences and health information technology companies face a unique set of privacy and data security concerns. Increasing media attention on data breaches involving health-related data has drawn ever-increasing scrutiny to regulatory compliance, particularly for publicly-traded companies. Both public and private companies face significant legal exposure, financial liability and reputational harm from data breaches.

Yet, the collection, analysis, storage and disclosure of health-related information is critical for developing and commercializing products, establishing strategic collaborations, securing regulatory approvals, and completing corporate acquisitions and other transactions. During this webinar, WilmerHale Partners Jonathan Cedarbaum, Barry Hurewitz and Brian Johnson address data privacy and security considerations for life sciences and health information technology companies, including:

  • the privacy landscape for the healthcare and life sciences industries;
  • how to navigate the complex regulatory framework governing health-related data;
  • which key contractual issues affect the third parties who handle your company’s data; and
  • practical tips for data security breach preparedness and response.

View the Webinar Recording
View the Presentation Materials

Read More About the Event



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.